Myriad Genetics Raises FY2026 Sales Guidance from $770.000M-$790.000M to $780.000M-$790.000M vs $777.921M Est
Benzinga Newsdesk 7 hours ago
NewsGuidance
Myriad Genetics (NASDAQ:MYGN) raises FY2026 sales outlook from $770.000 million-$790.000 million to $780.000 million-$790.000 million vs $777.921 million estimate.
Myriad Genetics (NASDAQ:MYGN) raises FY2026 sales outlook from $770.000 million-$790.000 million to $780.000 million-$790.000 million vs $777.921 million estimate.